Safety and efficacy of ledipasvir-sofosbuvir with or without ribavirin for chronic hepatitis C in children ages 6-11 | HCV Guidance

HCV Guidance: Recommendations for Testing, Managing, and Treating Hepatitis C

Safety and efficacy of ledipasvir-sofosbuvir with or without ribavirin for chronic hepatitis C in children ages 6-11

Murray KF, Balistreri WF, Bansal S, et al. Safety and efficacy of ledipasvir-sofosbuvir with or without ribavirin for chronic hepatitis C in children ages 6-11. Hepatology. 2018;68:2158-2166.

Publication Type:

Journal Article

Authors:

Murray, KF; Balistreri, WF; Bansal, S; et, al

Source:

Hepatology, Volume 68, p.2158-2166 (2018)

Cited On:

HCV in Children

Export Citation:

RIS Format

Top